Skip to main content
Top
Published in: Journal of Endocrinological Investigation 11/2018

01-11-2018 | Original Article

Clinical presentation and management of patients with primary hyperparathyroidism in Italy

Authors: F. Saponaro, F. Cetani, A. Repaci, U. Pagotto, C. Cipriani, J. Pepe, S. Minisola, C. Cipri, F. Vescini, A. Scillitani, A. Salcuni, S. Palmieri, C. Eller-Vainicher, I. Chiodini, B. Madeo, E. Kara, E. Castellano, G. Borretta, L. Gianotti, F. Romanelli, V. Camozzi, A. Faggiano, S. Corbetta, L. Cianferotti, M. L. Brandi, M. L. De Feo, A. Palermo, G. Vezzoli, F. Maino, M. Scalese, C. Marcocci

Published in: Journal of Endocrinological Investigation | Issue 11/2018

Login to get access

Abstract

Purpose

Evaluation of the phenotype of primary hyperparathyroidism (PHPT), adherence to International Guidelines for parathyroidectomy (PTx), and rate of surgical cure.

Method

From January 2014–January 2016, we performed a prospective, multicenter study in patients with newly diagnosed PHPT. Biochemical and instrumental data were collected at baseline and during 1-year follow-up.

Results

Over the first year we enrolled 604 patients (age 61 ± 14 years), mostly women (83%), referred for further evaluation and treatment advice. Five hundred sixty-six patients had sporadic PHPT (93.7%, age 63 ± 13  years), the remaining 38 (6.3%, age 41 ± 17  years) had familial PHPT. The majority of patients (59%) were asymptomatic. Surgery was advised in 281 (46.5%). Follow-up data were available in 345 patients. Eighty-seven of 158 (55.1%) symptomatic patients underwent PTx. Sixty-five (53.7%) of 121 asymptomatic patients with at least one criterion for surgery underwent PTx and 56 (46.3%) were followed without surgery. Negative parathyroid imaging studies predicted a conservative approach [symptomatic PHPT: OR 18.0 (95% CI 4.2–81.0) P < 0.001; asymptomatic PHPT: OR 10.8, (95% CI 3.1–37.15) P < 0.001). PTx was also performed in 16 of 66 (25.7%) asymptomatic patients without surgical criteria. Young age, serum calcium concentration, 24 h urinary calcium, positive parathyroid imaging (either ultrasound or MIBI scan positive in 75% vs. 16.7%, P = 0.001) were predictors of parathyroid surgery. Almost all (94%) of patients were cured by PTx.

Conclusions

Italian endocrinologists do not follow guidelines for the management of PHPT. Negative parathyroid imaging studies are strong predictors of a non-surgical approach. PTx is successful in almost all patients.
Literature
8.
20.
go back to reference Shah VN, Bhadada SK, Bhansali A et al (2014) Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res 139:694–699PubMedPubMedCentral Shah VN, Bhadada SK, Bhansali A et al (2014) Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res 139:694–699PubMedPubMedCentral
24.
go back to reference Zini M, Attanasio R, Cesareo R et al (2012) AME position statement: primary hyperparathyroidism in clinical practice. J Endocrinol Invest 35:2–21CrossRef Zini M, Attanasio R, Cesareo R et al (2012) AME position statement: primary hyperparathyroidism in clinical practice. J Endocrinol Invest 35:2–21CrossRef
25.
go back to reference Sharata A, Kelly LT, Rozenfeld Y et al (2017) Management of primary hyperparathyroidism: can we do better? Am Surg 83(1):64–70PubMed Sharata A, Kelly LT, Rozenfeld Y et al (2017) Management of primary hyperparathyroidism: can we do better? Am Surg 83(1):64–70PubMed
31.
go back to reference Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRef Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRef
35.
go back to reference Yeh MW, Wiseman JE, Chu SD et al (2011) Population-level predictors of persistent hyperparathyroidism. Surgery 150(6):1113–1119CrossRef Yeh MW, Wiseman JE, Chu SD et al (2011) Population-level predictors of persistent hyperparathyroidism. Surgery 150(6):1113–1119CrossRef
Metadata
Title
Clinical presentation and management of patients with primary hyperparathyroidism in Italy
Authors
F. Saponaro
F. Cetani
A. Repaci
U. Pagotto
C. Cipriani
J. Pepe
S. Minisola
C. Cipri
F. Vescini
A. Scillitani
A. Salcuni
S. Palmieri
C. Eller-Vainicher
I. Chiodini
B. Madeo
E. Kara
E. Castellano
G. Borretta
L. Gianotti
F. Romanelli
V. Camozzi
A. Faggiano
S. Corbetta
L. Cianferotti
M. L. Brandi
M. L. De Feo
A. Palermo
G. Vezzoli
F. Maino
M. Scalese
C. Marcocci
Publication date
01-11-2018
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 11/2018
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-018-0879-z

Other articles of this Issue 11/2018

Journal of Endocrinological Investigation 11/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.